Table of Content



Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 List Of Secondary Sources
1.8 Report Objectives
Chapter 2 Executive Summary
2.1 Cardiac Resynchronization Therapy (CRT) Market Outlook, 2017 - 2030 (USD Million)
2.2 Cardiac Resynchronization Therapy (CRT) Market Summary, 2021
Chapter 3 Cardiac Resynchronization Therapy (CRT) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Cardiac Resynchronization Therapy (CRT) Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Prevalence Of Cardiovascular Diseases
3.3.1.2 Technological Advancements
3.3.1.3 Rising Sedentary Lifestyle
3.3.1.4 Increasing Geriatric Population
3.3.2 Market Restraint Analysis
3.3.2.1 Product Recall
3.3.2.2 High Cost Of Device
3.4 Regulatory Framework
3.4.1 North America
3.4.2 Europe
3.4.3 Apac
3.4.4 Latam
3.4.5 Mea
3.5 Cardiac Resynchronization Therapy (CRT): Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.1.1 Bargaining Power Of Suppliers: Low
3.5.1.2 Bargaining Power Of Buyers: Low
3.5.1.3 Threat Of Substitutes: High
3.5.1.4 Threat Of New Entrants: Low
3.5.1.5 Competitive Rivalry: Moderate
3.5.2 Cardiac Resynchronization Therapy (CRT) - SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
3.5.2.1 Political & Legal Landscape
3.5.2.2 Economic Landscape
3.5.2.3 Social Landscape
3.5.2.4 Technology Landscape
Chapter 4 COVID-19 Impact Analysis
4.1 Disease Prevalence Analysis
4.2 COVID-19 Impact And Future Scenario
4.3 Impact On Market Players
4.3.1 Medtronic
4.3.2 Abbott
Chapter 5 Cardiac Resynchronization Therapy (CRT) Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2021 & 2030
5.2 Product Dashboard
5.3 CRT-D
5.3.1 CRT-D Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.4 CRT-P
5.4.1 CRT-P Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 6 Cardiac Resynchronization Therapy (CRT) Market: End-Use Estimates & Trend Analysis
6.1 End-Use Market Share Analysis, 2021 & 2030
6.2 End-Use Dashboard
6.3 Hospital
6.3.1 Hospital Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.4 Cardiac Centers
6.4.1 Cardiac Centers Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.5 Others
6.5.1 Other End-Users Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 7 Cardiac Resynchronization Therapy (CRT) Market: Regional Estimates & Trend Analysis, By Product, And End Use
7.1 Regional Market Snapshot
7.2 Region Market Share Analysis, 2021 & 2030
7.3 North America
7.3.1 North America Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4.2 UK
7.4.2.1 UK Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4.3 Germany
7.4.3.1 Germany Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4.4 France
7.4.4.1 France Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4.5 Italy
7.4.5.1 Italy Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4.6 Spain
7.4.6.1 Spain Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.3 China
7.5.3.1 China Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.4 India
7.5.4.1 India Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.5 Australia
7.5.5.1 Australia Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5.6 South Korea
7.5.6.1 South Korea Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6.2 Mexico
7.6.2.1 Mexico Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6.3 Brazil
7.6.3.1 Brazil Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7 Middle East & Africa (MEA)
7.7.1 MEA Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7.4 UAE
7.7.4.1 UAE Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Abbott
8.1.1.1 Company overview
8.1.1.2 Product benchmarking
8.1.1.3 Financial performance
8.1.1.4 Strategic initiatives
8.1.2 Boston Scientific Corp.
8.1.2.1 Company overview
8.1.2.2 Product benchmarking
8.1.2.3 Financial performance
8.1.2.4 Strategic initiatives
8.1.3 Medtronic
8.1.3.1 Company overview
8.1.3.2 Product benchmarking
8.1.3.3 Financial performance
8.1.3.4 Strategic initiatives
8.1.4 Biotronik Se & Co. KG
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Financial performance
8.1.4.4 Strategic initiatives
8.1.5 Microport Scientific Corp.
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Financial performance
8.1.5.4 Strategic initiatives
8.2 Market Participation Categorization
8.3 Company Market Position Analysis
8.4 Major Deals & Strategic Alliances Analysis



List of Figures

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Cardiac Resynchronization Therapy (CRT) market revenue, 2017 - 2030 (USD Million)
Fig. 11 Cardiac Resynchronization Therapy (CRT) market snapshot, 2021 (USD Million)
Fig. 12 Parent Market Analysis
Fig. 13 Ancillary Market Analysis
Fig. 14 Penetration & growth prospect mapping by product, 2021
Fig. 15 Cardiac Resynchronization Therapy (CRT) market dynamics
Fig. 16 Cardiac Resynchronization Therapy (CRT) market driver impact
Fig. 17 Population aged 65 Years and Above (% of Total Population), 2020
Fig. 18 Cardiac Resynchronization Therapy (CRT) market restraint impact
Fig. 19 COVID-19 confirmed cases around the world
Fig. 20 Cardiac Resynchronization Therapy (CRT) market: Product movement analysis
Fig. 21 Cardiac Resynchronization Therapy (CRT) market: Product dashboard
Fig. 22 Global CRT-D market, 2017 - 2030 (USD Million)
Fig. 23 Global CRT-P market, 2017 - 2030 (USD Million)
Fig. 24 Cardiac Resynchronization Therapy (CRT) market: End-Use movement analysis
Fig. 25 Cardiac Resynchronization Therapy (CRT) End-Use dashboard
Fig. 26 Prevalence of Heart, Stroke, and Vascular Disease Among Men Aged 18 & Above, By Age Group, 2017-2018
Fig. 27 Prevalence of Heart, Stroke, and Vascular Disease Among Women Aged 18 & Above, By Age Group, 2017-2018
Fig. 28 Global hospital market, 2017 - 2030 (USD Million)
Fig. 29 Global cardiac centers market, 2017 - 2030 (USD Million)
Fig. 30 Global other end-users markets, 2017 - 2030 (USD Million)
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 Regional outlook, 2021 & 2030
Fig. 33 North America Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 34 Leading causes of deaths in the U.S.
Fig. 35 U.S. Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 36 Canada Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 37 Europe Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 38 U.K. Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 39 Germany Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 40 France Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 41 Italy Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 42 CRT Devices Implanted in Spain in 2020
Fig. 43 Spain Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 44 Asia Pacific Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 45 Japan Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 46 China Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 47 India Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 48 Australia Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 49 South Korea Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 50 Latin America Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 51 Mexico Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 52 Brazil Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 53 Argentina Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 54 MEA Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 55 South Africa Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 56 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 57 UAE Cardiac Resynchronization Therapy (CRT) market, 2017 - 2030 (USD Million)
Fig. 58 Market Participant Categorization
Fig. 59 Company market position analysis
Fig. 60 Major deals & strategic alliances analysis

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 Global Cardiac Resynchronization Therapy market, by region, 2017 - 2030 (USD Million)
Table 3 Global Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 4 Global Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 5 North America Cardiac Resynchronization Therapy market, by country, 2017 - 2030 (USD Million)
Table 6 North America Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 7 North America Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 8 U.S. Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 9 U.S. Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 10 Canada Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 11 Canada Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 12 Europe Cardiac Resynchronization Therapy market, by country, 2017 - 2030 (USD Million)
Table 13 Europe Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 14 Europe Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 15 U.K. Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 16 U.K. Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 17 Germany Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 18 Germany Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 19 France Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 20 France Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 21 Italy Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 22 Italy Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 23 Spain Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 24 Spain Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 25 Asia Pacific Cardiac Resynchronization Therapy market, by country, 2017 - 2030 (USD Million)
Table 26 Asia Pacific Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 27 Asia Pacific Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 28 China Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 29 China Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 30 Japan Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 31 Japan Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 32 India Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 33 India Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 34 Australia Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 35 Australia Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 36 South Korea Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 37 South Korea Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 38 Latin America Cardiac Resynchronization Therapy market, by country, 2017 - 2030 (USD Million)
Table 39 Latin America Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 40 Latin America Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 41 Brazil Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 42 Brazil Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 43 Mexico Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 44 Mexico Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 45 Argentina Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 46 Argentina Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 47 MEA Cardiac Resynchronization Therapy market, by country, 2017 - 2030 (USD Million)
Table 48 MEA Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 49 MEA Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 50 South Africa Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 51 South Africa Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 52 Saudi Arabia Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 53 Saudi Arabia Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)
Table 54 UAE Cardiac Resynchronization Therapy market, by product, 2017 - 2030 (USD Million)
Table 55 UAE Cardiac Resynchronization Therapy market, by end user, 2017 - 2030 (USD Million)